Insider · CIK 0002077411
Bryan Daniel Baum
Files at SNTI (Senti Biosciences, Inc.). First filing -, latest -.
Bryan Daniel Baum files SEC Form 4 as director at SNTI (Senti Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bryan Daniel Baum has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 18, 2025 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +43,900 | $0.00 | $0 | 43,900 | Jul 21, 2025 |
Questions about Bryan Daniel Baum
Answered from the filings on this page, as of the latest one.
Is Bryan Daniel Baum buying or selling?
Bryan Daniel Baum has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bryan Daniel Baum's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bryan Daniel Baum has 0.
Where does Bryan Daniel Baum file Form 4?
Bryan Daniel Baum has filed Form 4 at SNTI (Senti Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.